Janus Henderson Income ETF
JIII$49.79 -0.05 (-0.10%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 7, 2026 | $0.24 | 2026-06-30 | 2026-06-30 |
| June 4, 2026 | $0.25 | 2026-05-29 | 2026-05-29 |
| May 6, 2026 | $0.25 | 2026-04-30 | 2026-04-30 |
| April 7, 2026 | $0.27 | 2026-03-31 | 2026-03-31 |
| March 5, 2026 | $0.27 | 2026-02-27 | 2026-02-27 |
Dividends Summary
- Consistent Payer: Janus Henderson Income ETF has rewarded shareholders with 19 dividend payments over the past 2 years.
- Total Returned Value: Investors who held JIII shares during this period received a total of $5.45 per share in dividend income.
- Latest Payout: The most recent dividend of $0.24/share was paid 11 days ago, on July 7, 2026.
- Yield & Schedule: JIII currently pays dividends monthly with an annual yield of 7.39%.
- Dividend Growth: Since 2024, the dividend payout has grown by 6.5%, from $0.22 to $0.24.
Company News
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
CAMP4 Therapeutics secured a private placement of up to $100 million to advance its first-in-class treatment for SYNGAP1-related disorders, with $50 million in upfront proceeds and potential additional funding contingent on clinical milestones.
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Invivyd completed a public offering of 89,234,480 shares and pre-funded warrants, raising approximately $57.5 million to fund clinical trials, research and development, and corporate purposes.
